Live Breaking News & Updates on Post Conference Perspectives

Stay updated with breaking news from Post conference perspectives. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Innovations Needed and Future Directions in Treatment of NSCLC

Concluding thoughts on data presented at ESMO 2023, and innovations still needed for improved survival of NSCLC provided by Patrick Forde, MBBCh. ....

Patrick Forde , Post Conference Perspectives , Adjuvant Targeted Therapy , Docetaxel Chemotherapy , Platinum Doublet Chemotherapy , Tropion Lung01 , Egfr Mutation , Mariposa Trial , Egfr Tki , Mariposa 2 ,

PAPILLON Trial Insights: ESMO 2023

Patrick Forde, MBBCh, discusses advances in EGFR Exon 20 insertion-mutated NSCLC. ....

Patrick Forde , Post Conference Perspectives , Egfr Exon 20 , Infusion Related Reactions ,

The Future of R/R B-ALL Treatment

Jae Park, MD, wraps up his discussion by highlighting exciting investigational agents on the horizon for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia. ....

Post Conference Perspectives , Cell Therapy , R Rb All , Mlb All , Acute Lymphoblastic Leukemia , B Cell Acute Lymphoblastic Leukemia , Relapsed Refractoryb Cell Acute Lymphoblastic Leukemia , B All Signs , B All Symptoms , Available Treatment Optionsb All , Zuma 3 , Cytokine Release Syndrome ,